Brian Joseph Lynch, SVP and General Counsel at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 8,300 shares at $277.77 ($2.3M) on 2022-12-23, disclosed to the SEC on 2022-12-28.
Open-market sale of $2.3M MDGL by SVP and General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $267.88 | 500 | $134K | 5.9% |
| 2 | $268.99 | 300 | $81K | 3.5% |
| 3 | $270.25 | 700 | $189K | 8.3% |
| 4 | $271.27 | 800 | $217K | 9.5% |
| 5 | $272.74 | 1,500 | $409K | 17.9% |
| 6 | $273.48 | 539 |
| $147K |
| 6.5% |
| 7 | $273.48 | 539 | $147K | 6.5% |
| 8 | $274.70 | 400 | $110K | 4.8% |
| 9 | $275.24 | 100 | $28K | 1.2% |
| 10 | $276.40 | 100 | $28K | 1.2% |
| 11 | $277.77 | 361 | $100K | 4.4% |
| 12 | $277.77 | 361 | $100K | 4.4% |
| 13 | $279.46 | 1,100 | $307K | 13.5% |
| 14 | $280.41 | 200 | $56K | 2.5% |
| 15 | $280.41 | 200 | $56K | 2.5% |
| 16 | $281.79 | 200 | $56K | 2.5% |
| 17 | $281.79 | 200 | $56K | 2.5% |
| 18 | $283.61 | 200 | $57K | 2.5% |
| Total | $274.62 avg | 8,300 | $2.3M | 100% |
| Filing → |
| MDGL | SELL | 2023-01-06 | $7.2M | — | Filing → |